Delcath Systems (DCTH) Announces Sale of 5 Million Common Shares
Tweet
Share
E-mailGet Alerts DCTH Hot Sheet
Join SI Premium – FREE
Delcath Systems, Inc. (NASDAQ: DCTH) announced the sale of 5,000,000 shares of its common stock pursuant to an underwriting agreement with Jefferies & Company, Inc. acting as the sole bookrunner.
The Company expects to use the net proceeds from the sale of the shares for general corporate purposes, including, but not limited to, commercialization of our products, obtaining regulatory approvals, funding of our clinical trials, capital expenditures and working capital.
The Company expects to use the net proceeds from the sale of the shares for general corporate purposes, including, but not limited to, commercialization of our products, obtaining regulatory approvals, funding of our clinical trials, capital expenditures and working capital.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
- Baiya International Group (BIYA) files $200M mixed shelf
- QSE closes $6M private placement with final tranche of $674K
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
